Member Info for 1pencil

No one saw it coming though, no indication before it happened which is often the way.

Once you start engaging with potential partners the next step is not a big one, but still a speculative guess all the same - from recent update.

· HUTCHMED will seek potential partnerships to commercialize its assets outside of China, to accelerate the availability of innovative medicines for patients globally.

onsolidground 08:32, fully agree, pandering to the media is not the way to go.

Actions speak louder than words with hefty share purchases from both Chair and CEO, has to be up there with some of the largest by management this year, could easily spin a story around that but hey ho does not fit..

Best option is not to click, each article is measured for 'engagement' how many clicks it generates, ad click through and so on...same with twitter

I think if it were to happen any approach would be on a friendly basis, after all the strategy update was a real change, no one was expecting that including the analysts.

Investors could regain confidence in Chinese tech stocks again as more than 100 companies including Alibaba and Baidu avoided being kicked off U.S. stock exchanges.

https://www.cnbc.com/2022/12/21/investments-could-flow-back-into-china-as-companies-avoid-us-delisting.html

The retail apocalypse isn't over: it's coming back to bite department stores, experts warn

https://www.businessinsider.com/kohls-nordstrom-and-others-could-see-closures-in-2023-2022-12?r=US&IR=T

Nike stock surges after earnings and revenue top expectations

While the focus on Nike Direct was largely to blame for the increased administrative expenses, the investment has paid off. Nike Direct sales were up 16% for the quarter at $5.4 billion and digital sales were up 25%.

https://www.cnbc.com/2022/12/20/nike-nke-q2-earnings-2023.html

..doh !

"whales"

Article looks pretty bland, also covers other companies in the sector - title maybe a bit of a click bait as THG well followed.

I would put the free float around 30-40% mark although this is just a guess based on Jup/Chrys selling along with other tracker funds.

Moving up, paying more to stay on a shrinking market place is probably not the way to go. In terms of remaining a listed company I think Matt and the team want to see it through come what may, that said if it becomes a total distraction from running the business then he may have to approach existing holders like QIA to help facilitate an MBO.

Personally as an investor I have no problem with governance or IR, keep a low profile is often the best way forward having worked in IR for many years, sometimes you just cannot win at that game, best not to play.

No wales but some tuna ..

https://www.vitacoco.de/

https://www.movementumuk.com/

Head down, keep going !

Would it not be a better idea to move THG over to the NASDAQ rather than mess around with moving up to Premium, there may not be any benefit with UK institutions too timid to take on the media.

The downside is its going to be spendy to do so, upside is more comparables plus better oversight - THG current share holder base is overseas anyway with several US tracker funds

THG is an international company with UK head quarters, NASDAQ move might be well supported by existing holders.

Agree, Hutch have alluded to partnering in their recent strategy update - its another step towards further commercialisation of their assets, makes it all the more attractive to potential buyers of the whole business, something that is equally likely imo.

If you think about the time and investment it has taken to get this far its crazy cheap to the right buyer.

https://www.instagram.com/p/CmWusLNojT8/?igshid=YmMyMTA2M2Y=

Two pieces of good news, one today -

Prop traders drop it almost 9%, very aggressive market making.

Yes, indeed GS, looks like there's a few buy orders being worked.

https://finance.yahoo.com/news/hutchmed-initiates-rolling-submission-nda-100000343.html

Some of these may have been posted individually already but good to have in list format.

This is a great pitch stack for new or prospective Ingenuity/THG clients.

https://www.thgingenuity.com/future-of-commerce?utm_source=zoho&utm_medium=email&utm_campaign=foc_content_distribution_email4

https://www.forbes.com/sites/brendanahern/2022/12/16/china-adrs-to-climb-the-great-wall-of-worry-as-pcaob-resets-hfcaa-clock-week-in-review/?sh=704cb6c47ee5

China CSRC has also confirmed although not much coverage which is surprising given the 'uninvestable' tag previously assigned by hedge funds, maybe they are waiting to unwind short positions first..now there's a thing..

http://www.csrc.gov.cn/csrc_en/c102030/c6913420/content.shtml

AstraZeneca China signed a major collaboration agreement with the UK life and health sciences incubation platform MedCity on Thursday during the 2022 Beijing Intelligent Health Technology and Innovation Forum which was held online, a move to promote innovation exchange between Chinese and global healthcare industries.

http://www.chinadaily.com.cn/a/202212/15/WS639b1dd6a31057c47eba49d2.html

Washington, DC, Dec. 15, 2022

Public Company Accounting Oversight Board (PCAOB) Chair Erica Y. Williams released the following statement today after the Board determined the PCAOB was able to secure complete access to inspect and investigate audit firms in the People’s Republic of China (PRC) for the first time in history, in 2022.

https://pcaobus.org/news-events/news-releases/news-release-detail/pcaob-secures-complete-access-to-inspect-investigate-chinese-firms-for-first-time-in-history

Sorry, that article is from Aug 22, from FT piece

"US regulators said on Thursday that they had been allowed to inspect the work of auditors in China for the first time, easing the threat that about 200 Chinese companies could be thrown off the US stock market."

Sorry, that article is from Aug 22, from FT piece

"US regulators said on Thursday that they had been allowed to inspect the work of auditors in China for the first time, easing the threat that about 200 Chinese companies could be thrown off the US stock market."